AURORA CANNABIS IN COM NPV (OTCMKTS:ACBFF) is among those stocks that we’ve stuck with for the longest here on Street Register, never letting too much time elapse between mentions. That is is part because of the Canadian company’s tenacity in pursuing its strategic objectives.
We watched as Aurora went from a minority shareholder, to taking over CanniMed, even in the face of attempted subversion by the CanniMed board. Now the task has been to proceed with the integration of CanniMed, and that began with the appointment of an interim CEO from in-house to replace the departing CEO, Brent Zettl.
AURORA CANNABIS IN COM NPV (OTCMKTS:ACBFF) chose its own Senior VP of Business Integration Andrċ Jérôme for the position. He is currently responsible for the integration of acquisitions, as well as for the identification of potential synergies across existing subsidiaries and joint venture partners. Mr. Jérôme, a member of the Bar of Québec for the last 23 years, joined Aurora from H2 Biopharma, where he was CEO and co-founder. Mr. Jérôme was already tasked with heading up the integration of CanniMed into the Aurora organization.
Terry Booth, Aurora CEO, said, “Andrċ is the right person to take on the role of Interim CEO at CanniMed. He is a consummate business professional and team leader with an excellent track record in accelerating growth … The integration of Aurora and CanniMed is well underway, and we anticipate updating the market frequently on developments as CanniMed is aligned with the Aurora Standard and expands its footprint in the domestic and international medical cannabis sectors.” (Source: Canada Newswire)
Meanwhile, things have continued to run smoothly with CanniMed- the company entered into a Letter of Intent to become a preferred supplier of medical cannabis to Pharmasave. A member governed cooperative of more than 650 independently owned community pharmacies across Canada, Pharmasave is one of the country’s leading independent community pharmacies.
Subject to changes to regulations that would allow such distribution, CanniMed and Aurora will supply and distribute high-quality medical cannabis, produced at the companies’ GMP compliant and GMP certified facilities, through Pharmasave pharmacists across Canada.
For more than a year, Pharmasave has been educating its pharmacists to ensure they are prepared to support patients and physicians in medication management. This includes how medical cannabis may affect other medications the patient may take, any health conditions they might have, and insights on how to identify and address mental health and addiction concerns in patients. (Source: Canada Newswire)
Of course, in addition to the CanniMed plotline, we also have Aurora’s massive cannabis production network, which is reaching gargantuan proportions and growing all the time.
The Canadian cannabis market, in the next few years, could be worth anywhere from five to twenty billion dollars a year. Not only has Aurora been preparing for the recreational cannabis market which kicks off in July, but it has also aggressively pushed for expansion outside of Canadian borders to diversify its portfolio. It’s that driving initiative that has made this company one of our favorites in the Canadian marijuana space for a very long time. We’ll be sure to continue looking out for key events. We’ll stay up on any further developments with ACBFF and pass them along to you! Stay locked on StreetRegister.com and be sure you’re signed up for our 100% free small cap newsletter. It’s as easy as that! Simply submit your primary active email address in the box below. Subscribe now!
Disclosure: No one at Street Register has been compensated in any way for the publishing of this article, nor do we hold any position in ACBFF stock, short or long.